Related Experiment Videos

Prostaglandin E1 and arterial occlusive disease: pharmacological considerations

T Simmet¹, B A Peskar

¹Institute of Pharmacology and Toxicology, Ruhr-University of Bochum, FRG.

European Journal of Clinical Investigation

|December 1, 1988

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Quantum Effects in Higher-Order Correlators of a Quantum-Dot Spin Qubit.

Physical review letters·2016

Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity.

Journal of controlled release : official journal of the Controlled Release Society·2016

Kallikrein inhibitors limit kinin B(2) antagonist-induced progression of oedematous to haemorrhagic pancreatitis in rats.

British journal of pharmacology·2008

CRTH2 is not involved in the anti-enteropooling effect of PGD2 in the small intestine.

Pharmacology·2008

A novel antagonist of CRTH2 blocks eosinophil release from bone marrow, chemotaxis and respiratory burst.

Allergy·2007

Enriching suicide gene bearing tumor cells for an increased bystander effect.

Cancer gene therapy·2006

See all related articles